← All trials
NCT07124819
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 22, 2024
- Primary completion
- Jan 14, 2025
- Completion date
- Jan 14, 2025
- First posted
- Aug 15, 2025
- Last posted
- Aug 15, 2025
- Enrollment
- 215
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of RussiaLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.